source
- Regeneron secures FDA approval for Pasatru, second U.S. treatment for rare bone disease FOPRegeneron received FDA approval for its antibody garetosmab, marketed as Pasatru, for treatment of fibrodysplasia ossificans progressiva (FOP) in adults. The approval makes Pasatru the second ther…
- Argon Medical issues correction for convenience kits containing lidocaine ampules after FDA safety alertArgon Medical has sent a correction notice to customers about certain convenience kits that include lidocaine HCl ampules supplied by Spectra Medical Devices. The FDA has classified this correctio…